AAAAAA
Results: 1-25/28
Authors:
TOMA S
ISNARDI L
RICCARDI L
BOLLAG W
Citation: S. Toma et al., INDUCTION OF APOPTOSIS IN MCP-7 BREAST-CARCINOMA CELL-LINE BY RAR ANDRXR SELECTIVE RETINOIDS, Anticancer research, 18(2A), 1998, pp. 935-942
ENHANCEMENT OF ANTIANGIOGENIC AND ANTINEOPLASTIC ACTIVITY OF IL-12 BYTHE COMBINATION WITH CALCITRIOL
Authors:
NOWICKA D
ZAGOZDZON R
MAJEWSKI S
MARCZAK M
BOLLAG W
JABLONSKA S
Citation: D. Nowicka et al., ENHANCEMENT OF ANTIANGIOGENIC AND ANTINEOPLASTIC ACTIVITY OF IL-12 BYTHE COMBINATION WITH CALCITRIOL, Journal of investigative dermatology, 110(4), 1998, pp. 523-523
Authors:
TOMA S
ISNARDI L
RAFFO P
RICCARDI L
DASTOLI G
APFEL C
LEMOTTE P
BOLLAG W
Citation: S. Toma et al., RAR-ALPHA ANTAGONIST RO-41-5253 INHIBITS PROLIFERATION AND INDUCES APOPTOSIS IN BREAST-CANCER CELL-LINES, International journal of cancer, 78(1), 1998, pp. 86-94
Authors:
OTT F
BOLLAG W
GEIGER JM
Citation: F. Ott et al., RETINOIDS IN LICHEN-PLANUS - REPLY, Dermatology, 194(3), 1997, pp. 312-312
Authors:
SKOPINSKA M
MAJEWSKI S
BOLLAG W
JABLONSKA S
Citation: M. Skopinska et al., CALCITRIOL AND ISOTRETINOIN COMBINED THERAPY FOR PRECANCEROUS AND CANCEROUS SKIN-LESIONS, Journal of dermatological treatment, 8(1), 1997, pp. 5-10
Authors:
MAJEWSKI S
NOWICKA D
ZAGOZDZON R
MARCZAK M
BOLLAG W
JABLONSKA S
Citation: S. Majewski et al., ENHANCEMENT OF ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF INTERLEUKIN-12 (IL-12) BY CALCITRIOL AND 9-CIS RETINOIC ACID, Journal of investigative dermatology, 109(3), 1997, pp. 436-436
Authors:
MAJEWSKI S
SKOPINSKA M
MARCZAK M
NOWICKA D
SZMURLO A
BOLLAG W
JABLONSKA S
Citation: S. Majewski et al., SYNERGISTIC ANTICANCER ACTION OF RETINOIDS, VITAMIN-D3 AND CYTOKINES (INTERFERONS AND INTERLEUKIN-12) AS RELATED TO THE ANTIANGIOGENIC AND ANTIPROLIFERATIVE EFFECTS, Journal of investigative dermatology, 108(4), 1997, pp. 202-202
Authors:
TOMA S
ISNARDI L
RAFFO P
DASTOLI G
DEFRANCISCI E
RICCARDI L
PALUMBO R
BOLLAG W
Citation: S. Toma et al., EFFECTS OF ALL-TRANS-RETINOIC ACID AND 13-CIS-RETINOIC ACID ON BREAST-CANCER CELL-LINES - GROWTH-INHIBITION AND APOPTOSIS INDUCTION, International journal of cancer, 70(5), 1997, pp. 619-627
Authors:
BOLLAG W
ISNARDI L
JABLONSKA S
KLAUS M
MAJEWSKI S
PIRSON W
TOMA S
Citation: W. Bollag et al., LINKS BETWEEN PHARMACOLOGICAL PROPERTIES OF RETINOIDS AND NUCLEAR RETINOID RECEPTORS, International journal of cancer, 70(4), 1997, pp. 470-472
Authors:
GEISEN C
DENK C
GREMM B
BAUST C
KARGER A
BOLLAG W
SCHWARZ E
Citation: C. Geisen et al., HIGH-LEVEL EXPRESSION OF THE RETINOIC ACID RECEPTOR-BETA GENE IN NORMAL-CELLS OF THE UTERINE CERVIX IS REGULATED BY THE RETINOIC ACID RECEPTOR-ALPHA AND IS ABNORMALLY DOWN-REGULATED IN CERVICAL-CARCINOMA CELLS, Cancer research, 57(8), 1997, pp. 1460-1467
Authors:
OTT F
BOLLAG W
GEIGER JM
Citation: F. Ott et al., ORAL 9-CIS-RETINOIC ACID VERSUS 13-CIS-RETINOIC ACID IN ACNE THERAPY, Dermatology, 193(2), 1996, pp. 124-126
Authors:
OTT F
BOLLAG W
GEIGER JM
Citation: F. Ott et al., EFFICACY OF ORAL LOW-DOSE TRETINOIN (ALL-TRANS-RETINOIC ACID) IN LICHEN-PLANUS, Dermatology, 192(4), 1996, pp. 334-336
Authors:
BOLLAG W
Citation: W. Bollag, THE RETINOID REVOLUTION, The FASEB journal, 10(9), 1996, pp. 938-939
Authors:
MAJEWSKI S
MARCZAK M
SZMURLO A
NOWICKA D
WROBEL A
BOLLAG W
JABLONSKA S
Citation: S. Majewski et al., ANTITUMOR ACTION OF INTERLEUKIN-12, RETINOIDS AND VITAMIN-D3 AS RELATED TO THEIR ANTIANGIOGENIC ACTIVITY, Journal of investigative dermatology, 107(3), 1996, pp. 89-89
Authors:
MAJEWSKI S
MARCZAK M
SZMURLO A
JABLONSKA S
BOLLAG W
Citation: S. Majewski et al., INTERLEUKIN-12 INHIBITS ANGIOGENESIS INDUCED BY HUMAN TUMOR CELL-LINES IN-VIVO, Journal of investigative dermatology, 106(5), 1996, pp. 1114-1118
Authors:
RUSTIN GJS
QUINNELL TG
JOHNSON J
CLARKE H
NELSTROP AE
BOLLAG W
Citation: Gjs. Rustin et al., TRIAL OF ISOTRETINOIN AND CALCITRIOL MONITORED BY CA-125 IN PATIENTS WITH OVARIAN-CANCER, British Journal of Cancer, 74(9), 1996, pp. 1479-1481
Authors:
MAJEWSKI S
MARCZAK M
SZMURLO A
JABLONSKA S
BOLLAG W
Citation: S. Majewski et al., RETINOIDS, INTERFERON-ALPHA, 1,25-DIHYDROXYVITAMIN D-3 AND THEIR COMBINATION INHIBIT ANGIOGENESIS INDUCED BY NON-HPV-HARBORING TUMOR-CELL LINES - RAR-ALPHA MEDIATES THE ANTIANGIOGENIC EFFECT OF RETINOIDS, Cancer letters, 89(1), 1995, pp. 117-124
Authors:
MAJEWSKI S
MARCZAK M
SZMURLO A
NOSZCZYK M
SKOPINSKA M
JABLONSKA S
BOLLAG W
Citation: S. Majewski et al., RETINOIDS AND 1,25-DIHYDROXYVITAMIN-D3 (VD3) SYNERGISTICALLY INHIBIT ANGIOGENIC POTENTIAL OF HUMAN TRANSFORMED EPITHELIAL-CELL LINES, Journal of investigative dermatology, 104(4), 1995, pp. 604-604
Authors:
BOLLAG W
MAJEWSKI S
JABLONSKA S
Citation: W. Bollag et al., CANCER COMBINATION CHEMOTHERAPY WITH RETINOIDS - EXPERIMENTAL RATIONALE, Leukemia, 8(9), 1994, pp. 1453-1457
Authors:
BOLLAG W
MAJEWSKI S
JABLONSKA S
Citation: W. Bollag et al., CANCER COMBINATION CHEMOTHERAPY WITH RETINOIDS - EXPERIMENTAL RATIONALE, Leukemia, 8, 1994, pp. 11-15
Authors:
EISENHAUER EA
LIPPMAN SM
KAVANAGH JJ
PARADESESPINOZA M
ARNOLD A
HONG WK
MASSIMINI G
SCHLEUNIGER U
BOLLAG W
HOLDENER EE
KRAKOFF I
Citation: Ea. Eisenhauer et al., COMBINATION 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A IN THE THERAPY OF SOLID TUMORS, Leukemia, 8, 1994, pp. 38-41
Authors:
EISENHAUER EA
LIPPMAN SM
KAVANAGH JJ
PARADESESPINOZA M
ARNOLD A
HONG WK
MASSIMINI G
SCHLEUNIGER U
BOLLAG W
HOLDENER EE
KRAKOFF I
Citation: Ea. Eisenhauer et al., COMBINATION 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A IN THE THERAPY OF SOLID TUMORS, Leukemia, 8(10), 1994, pp. 1622-1625
Authors:
BOLLAG W
Citation: W. Bollag, EXPERIMENTAL BASIS OF CANCER COMBINATION CHEMOTHERAPY WITH RETINOIDS,CYTOKINES, 1,25-DIHYDROXYVITAMIN D-3, AND ANALOGS, Journal of cellular biochemistry, 56(4), 1994, pp. 427-435
Authors:
MAJEWSKI S
SKOPINSKA M
BOLLAG W
JABLONSKA S
Citation: S. Majewski et al., COMBINATION OF ISOTRETINOIN AND CALCITRIOL FOR PRECANCEROUS AND CANCEROUS SKIN-LESIONS, Lancet, 344(8935), 1994, pp. 1510-1511
Authors:
BOLLAG W
Citation: W. Bollag, RETINOIDS IN ONCOLOGY - EXPERIMENTAL AND CLINICAL ASPECTS, Pure and applied chemistry, 66(5), 1994, pp. 995-1002